Nephrada · FSGS · United States · Renal pathologist · captured by Dr. Anna Becker on 07 Jan 2026 · reviewed by Dr. Marcus Lindqvist on 12 Jan 2026
Verbatim as captured; never edited
Renal pathologist at MD Anderson Cancer Center raised proteinuria as surrogate endpoint during a congress meeting. They requested supporting literature and a follow-up discussion.
Human-approved by Dr. Marcus Lindqvist on 12 Jan 2026
Proteinuria as surrogate endpoint: interest in collaboration reported by renal pathologist (US).
helixor-private-llm-2026.05 · generated 07 Jan 2026, 10:00 UTC
AI summary
Proteinuria as surrogate endpoint raised by renal pathologist; aligns with HEOR.
Source spans used by the model
Renal pathologist at MD Anderson Cancer Center raised proteinuria as surrogate endpoint during a congress meeting. They requested supporting literature and a follow-up discussion.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Patient experience | Patient experience |
| Function | HEOR | HEOR |
| Priority | Medium | Medium |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 5 | 20% | 20.0 |
| Strategic alignment | 2 | 20% | 8.0 |
| Scientific importance | 2 | 15% | 6.0 |
| Urgency | 4 | 15% | 12.0 |
| Novelty | 1 | 10% | 2.0 |
| Actionability | 2 | 10% | 4.0 |
| Confidence | 4 | 5% | 4.0 |
| Breadth of occurrence | 1 | 5% | 1.0 |
| Total | Medium 57 | ||
| Time | Action | User | Field | Change | Reason | Source |
|---|---|---|---|---|---|---|
| 09 Sept 2026, 09:27 UTC | Update | FAFatima Al-Sayed | dueDate | In progress → In progress | — | UI |
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
07 Jan 2026 · Dr. Hiroshi Petit, MD Anderson Cancer Center · MSL Dr. Anna Becker
Insight
Reviewed 12 Jan 2026 by Dr. Marcus Lindqvist
Action
Initiative
Decision
Outcome
Closure
Addressed in scientific platform update.
No other insights on this topic.